SCHEDULE: Altium Capital Discloses 3.11% Stake in LogicMark

Altium Capital Management LLC and its affiliates have disclosed a 3.11% beneficial ownership stake in LogicMark, Inc. through Series A Warrants.

Summary

• Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP, and Altium Healthcare Long Short GP LLC jointly reported beneficial ownership in LogicMark, Inc.
• The aggregate beneficial ownership stands at 1,881,534 shares of Common Stock.
• This represents 3.11% of LogicMark's outstanding Common Stock.
• The ownership is primarily derived from Series A Warrants.
• The reported share count of 1,881,534 includes shares issuable upon full conversion and exercise of these warrants.
• The percentage is calculated based on 60,588,224 shares of Common Stock outstanding as of March 27, 2025.
• The reporting persons have shared voting and shared dispositive power over all 1,881,534 shares.

Sentiment

Score: 4

Explanation: The filing is a standard disclosure of beneficial ownership. However, as an amendment reporting a stake below 5%, it potentially indicates a reduction in the investor's position, which could be viewed slightly negatively.

Positives

• Altium Capital Management LLC, a specialized healthcare fund, maintains a beneficial ownership stake in LogicMark, Inc., indicating continued interest in the company.

Negatives

• The filing is an amendment (Amendment No. 1) and reports a 3.11% stake, which is below the 5% threshold often associated with significant institutional holdings. This could imply a reduction in their stake from a previous higher level, which might be viewed negatively by the market.
• The 9.99% warrant blocker limits Altium's ability to increase its stake beyond this threshold through warrant exercise, potentially capping their influence or upside from warrant conversion.
• The actual number of beneficially owned shares, after giving effect to the warrant blocker, is less than the reported 1,881,534 shares, which could imply a lower immediate impact or a more limited current stake than the headline number suggests.

Risks

• The Series A Warrants are subject to a 9.99% blocker, meaning Altium Capital cannot exercise them to the extent that their beneficial ownership would exceed 9.99% of LogicMark's outstanding Common Stock. This limits their potential ownership and influence.
• The reported beneficial ownership of 1,881,534 shares does not account for the warrant blocker, meaning the actual exercisable or currently owned shares are lower than this figure.
• A potential reduction in Altium Capital's stake (implied by the "Amendment No. 1" and the current 3.11% ownership) could signal a decrease in confidence from a significant institutional investor.

Future Outlook

NA

Industry Context

This filing indicates an investment by a healthcare-focused fund (Altium Healthcare Long Short Onshore Fund LP) in LogicMark, Inc., which operates in the personal emergency response systems (PERS) and remote patient monitoring (RPM) sectors. This suggests that Altium Capital sees value or potential in the healthcare technology or medical device space, aligning with broader trends of increased investment in digital health and aging-in-place solutions.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake, which could be viewed positively as a vote of confidence or negatively if it implies a potential future sale.
• Company Management: Awareness of a significant institutional holder, which may influence strategic decisions or engagement.

Key Dates

Keywords

LogicMark, Altium Capital, SEC filing, Schedule 13G, beneficial ownership, common stock, warrants, institutional investment, healthcare fund